| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 158.170.714 $ | 99,51 | 2.361.595 | |||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 16.206.347 $ | 10,20 | 17.620 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 6.559.468 $ | 4,13 | 13.345 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 5.898.367 $ | 3,71 | 12.795 | |
| Stryker Corp. | Stryker Corp. | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 5.616.589 $ | 3,53 | 17.093 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 5.532.859 $ | 3,48 | 45.996 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 5.099.715 $ | 3,21 | 25.858 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 4.950.715 $ | 3,11 | 18.296 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 4.830.604 $ | 3,04 | 6.615 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 4.626.230 $ | 2,91 | 21.271 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 4.313.649 $ | 2,71 | 5.583 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 4.242.005 $ | 2,67 | 30.437 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 3.944.039 $ | 2,48 | 16.135 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.931.338 $ | 2,47 | 8.804 | |
| Danaher Corp. | Danaher Corp. | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 3.310.037 $ | 2,08 | 17.458 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 2.678.724 $ | 1,69 | 8.096 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 2.324.583 $ | 1,46 | 10.163 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 2.223.330 $ | 1,40 | 22.862 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 2.165.563 $ | 1,36 | 3.652 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd., Class H | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 2.229.227 $ | 1,40 | 88.194 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 1.861.025 $ | 1,17 | 67.185 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.836.173 $ | 1,16 | 17.421 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.737.891 $ | 1,09 | 10.628 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 1.717.757 $ | 1,08 | 90.599 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 1.700.915 $ | 1,07 | 8.505 | |
| Tenet Healthcare Corp. | Tenet Healthcare Corp. | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 1.682.727 $ | 1,06 | 8.917 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.624.843 $ | 1,02 | 4.618 | |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 1.609.124 $ | 1,01 | 37.764 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 1.529.469 $ | 0,96 | 24.374 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 1.509.162 $ | 0,95 | 3.189 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 1.469.330 $ | 0,92 | 15.907 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 1.416.147 $ | 0,89 | 19.718 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 1.298.491 $ | 0,82 | 15.590 | |
| Cigna Group (The) | Cigna Group (The) | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 1.237.720 $ | 0,78 | 4.640 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 1.179.121 $ | 0,74 | 17.422 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 1.163.473 $ | 0,73 | 5.506 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.116.717 $ | 0,70 | 4.323 | |
| Elevance Health, Inc. | Elevance Health, Inc. | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 1.104.839 $ | 0,70 | 3.774 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 1.041.799 $ | 0,66 | 21.192 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.017.620 $ | 0,64 | 13.552 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 1.007.782 $ | 0,63 | 13.571 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 967.278 $ | 0,61 | 20.068 | |
| Chugai Pharmaceutical Co. Ltd. | Chugai Pharmaceutical Co. Ltd. | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 951.648 $ | 0,60 | 17.200 | |
| Celcuity, Inc. | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 932.524 $ | 0,59 | 8.170 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 928.552 $ | 0,58 | 2.882 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 924.526 $ | 0,58 | 19.273 | |
| Centessa Pharmaceuticals plc | Centessa Pharmaceuticals plc | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 897.910 $ | 0,56 | 22.606 | |
| Cencora, Inc. | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 880.534 $ | 0,55 | 2.803 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 772.496 $ | 0,49 | 19.202 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 743.726 $ | 0,47 | 8.836 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 730.673 $ | 0,46 | 7.132 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 721.882 $ | 0,45 | 6.483 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 703.583 $ | 0,44 | 8.786 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 699.048 $ | 0,44 | 13.859 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 678.323 $ | 0,43 | 7.207 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 674.381 $ | 0,42 | 8.036 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 674.062 $ | 0,42 | 10.227 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 644.353 $ | 0,41 | 17.741 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 627.117 $ | 0,39 | 1.198 | |
| Immunome, Inc. | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 570.807 $ | 0,36 | 26.100 | |
| IQVIA Holdings, Inc. | IQVIA Holdings, Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 567.898 $ | 0,36 | 3.330 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 557.200 $ | 0,35 | 14.617 | |
| Belite Bio, Inc. | Belite Bio, Inc. | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 526.152 $ | 0,33 | 3.300 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 510.197 $ | 0,32 | 31.015 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 482.316 $ | 0,30 | 5.221 | |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 470.368 $ | 0,30 | 8.922 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 444.652 $ | 0,28 | 8.753 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 435.903 $ | 0,27 | 2.579 | |
| Alignment Healthcare, Inc. | Alignment Healthcare, Inc. | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 430.915 $ | 0,27 | 24.456 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 416.042 $ | 0,26 | 8.482 | |
| Revvity, Inc. | Revvity, Inc. | EC | 714046109 | Long | Börsenkurs (Stufe 1) | 414.132 $ | 0,26 | 4.727 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 411.639 $ | 0,26 | 17.274 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 410.309 $ | 0,26 | 18.625 | |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 401.024 $ | 0,25 | 1.600 | |
| Sonova Holding AG | Sonova Holding AG (Registered) | EC | CH0012549785 | Long | Modellwert (Stufe 2) | 389.651 $ | 0,25 | 1.719 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 383.060 $ | 0,24 | 9.555 | |
| IDEXX Laboratories, Inc. | IDEXX Laboratories, Inc. | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 375.904 $ | 0,24 | 669 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 372.080 $ | 0,23 | 12.465 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 369.883 $ | 0,23 | 4.253 | |
| McKesson Corp. | McKesson Corp. | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 359.990 $ | 0,23 | 416 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 357.611 $ | 0,22 | 28.225 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 347.539 $ | 0,22 | 11.527 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 346.036 $ | 0,22 | 11.059 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 337.020 $ | 0,21 | 18.849 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 330.522 $ | 0,21 | 21.324 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 329.865 $ | 0,21 | 5.261 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 328.454 $ | 0,21 | 20.300 | |
| Billiontoone, Inc. | Billiontoone, Inc., Class A | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 320.339 $ | 0,20 | 4.058 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 311.005 $ | 0,20 | 5.352 | |
| Bio-Rad Laboratories, Inc. | Bio-Rad Laboratories, Inc., Class A | EC | 090572207 | Long | Börsenkurs (Stufe 1) | 308.576 $ | 0,19 | 1.107 | |
| MoonLake Immunotherapeutics | MoonLake Immunotherapeutics, Class A | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 304.783 $ | 0,19 | 16.351 | |
| Palvella Therapeutics, Inc. | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 296.044 $ | 0,19 | 2.375 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 296.021 $ | 0,19 | 8.055 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 286.639 $ | 0,18 | 8.755 | |
| Celldex Therapeutics, Inc. | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 273.173 $ | 0,17 | 8.612 | |
| Encompass Health Corp. | Encompass Health Corp. | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 271.328 $ | 0,17 | 2.805 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 269.988 $ | 0,17 | 8.292 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 254.043 $ | 0,16 | 25.532 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 252.225 $ | 0,16 | 12.681 | |
| Repligen Corp. | Repligen Corp. | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 247.422 $ | 0,16 | 2.100 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 242.824 $ | 0,15 | 33.493 | |
| Kestra Medical Technologies Ltd. | Kestra Medical Technologies Ltd. | EC | BMG524411052 | Long | Börsenkurs (Stufe 1) | 241.631 $ | 0,15 | 12.124 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 241.500 $ | 0,15 | 1.400 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 237.668 $ | 0,15 | 3.388 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 228.202 $ | 0,14 | 3.569 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 225.168 $ | 0,14 | 92.282 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 219.855 $ | 0,14 | 5.712 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 209.200 $ | 0,13 | 10.000 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 207.659 $ | 0,13 | 27.145 | |
| Molina Healthcare, Inc. | Molina Healthcare, Inc. | EC | 60855R100 | Long | Börsenkurs (Stufe 1) | 201.683 $ | 0,13 | 1.513 | |
| Sartorius AG | Sartorius AG (Preference) | EC | DE0007165631 | Long | Modellwert (Stufe 2) | 200.591 $ | 0,13 | 822 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 198.153 $ | 0,12 | 22.961 | |
| Viatris, Inc. | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 197.246 $ | 0,12 | 14.600 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 196.959 $ | 0,12 | 6.972 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 190.575 $ | 0,12 | 22.500 | |
| Climb Bio, Inc. | Climb Bio, Inc. | EC | 28658R106 | Long | Börsenkurs (Stufe 1) | 190.430 $ | 0,12 | 27.800 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 187.625 $ | 0,12 | 5.631 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 183.840 $ | 0,12 | 4.800 | |
| Biohaven Ltd. | Biohaven Ltd. | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 183.531 $ | 0,12 | 21.694 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 180.783 $ | 0,11 | 12.357 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 177.429 $ | 0,11 | 11.900 | |
| Shattuck Labs, Inc. | Shattuck Labs, Inc. | EC | 82024L103 | Long | Börsenkurs (Stufe 1) | 171.681 $ | 0,11 | 26.700 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 168.067 $ | 0,11 | 350 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 167.002 $ | 0,11 | 8.698 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 159.673 $ | 0,10 | 45.491 | |
| Generate Biomedicines, Inc. | Generate Biomedicines, Inc. | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 158.750 $ | 0,10 | 12.700 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 153.468 $ | 0,10 | 10.800 | |
| PROCEPT BioRobotics Corp. | PROCEPT BioRobotics Corp. | EC | 74276L105 | Long | Börsenkurs (Stufe 1) | 150.860 $ | 0,09 | 6.032 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 148.620 $ | 0,09 | 3.938 | |
| Lantheus Holdings, Inc. | Lantheus Holdings, Inc. | EC | 516544103 | Long | Börsenkurs (Stufe 1) | 144.115 $ | 0,09 | 1.900 | |
| Atrium Therapeutics, Inc. | Atrium Therapeutics, Inc. | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 139.048 $ | 0,09 | 10.400 | |
| Viridian Therapeutics, Inc. | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 124.773 $ | 0,08 | 6.379 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 118.186 $ | 0,07 | 9.365 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 113.002 $ | 0,07 | 9.370 | |
| SpyGlass Pharma, Inc. | SpyGlass Pharma, Inc. | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 109.185 $ | 0,07 | 4.214 | |
| Sensorion SA | Sensorion SA | EC | FR0012596468 | Long | Modellwert (Stufe 2) | 108.532 $ | 0,07 | 227.583 | |
| Zai Lab Ltd. | Zai Lab Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 102.966 $ | 0,06 | 5.474 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 101.186 $ | 0,06 | 2.991 | |
| Immatics NV | Immatics NV | EC | NL0015285941 | Long | Börsenkurs (Stufe 1) | 99.384 $ | 0,06 | 10.100 | |
| Inspire Medical Systems, Inc. | Inspire Medical Systems, Inc. | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 98.002 $ | 0,06 | 1.900 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 96.600 $ | 0,06 | 20.819 | |
| Alto Neuroscience, Inc. | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 92.168 $ | 0,06 | 4.100 | |
| Evommune, Inc. | Evommune, Inc. | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 92.144 $ | 0,06 | 4.008 | |
| Aktis Oncology, Inc. | Aktis Oncology, Inc. | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 87.017 $ | 0,05 | 4.864 | |
| Crescent Biopharma, Inc. | Crescent Biopharma, Inc. | EC | KYG2545C1042 | Long | Börsenkurs (Stufe 1) | 81.085 $ | 0,05 | 4.414 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 66.855 $ | 0,04 | 12.686 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 60.702 $ | 0,04 | 16.956 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 58.912 $ | 0,04 | 10.634 | |
| BridgeBio Oncology Therapeutics, Inc. | BridgeBio Oncology Therapeutics, Inc., Class A | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 58.891 $ | 0,04 | 6.580 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 58.729 $ | 0,04 | 1.900 | |
| Eikon Therapeutics, Inc. | Eikon Therapeutics, Inc. | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 53.651 $ | 0,03 | 5.071 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 48.817 $ | 0,03 | 7.297 | |
| Immix Biopharma, Inc. | Immix Biopharma, Inc. | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 45.550 $ | 0,03 | 5.000 | |
| Hims & Hers Health, Inc. | Hims & Hers Health, Inc. | EC | 433000106 | Long | Börsenkurs (Stufe 1) | 35.292 $ | 0,02 | 1.700 | |
| Saluda Medical, Inc. | Saluda Medical, Inc. | EC | AU0000432114 | Long | Modellwert (Stufe 2) | 32.946 $ | 0,02 | 57.441 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 32.292 $ | 0,02 | 1.300 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 31.360 $ | 0,02 | 800 | |
| Monopar Therapeutics, Inc. | Monopar Therapeutics, Inc. | EC | 61023L207 | Long | Börsenkurs (Stufe 1) | 31.285 $ | 0,02 | 571 | |
| RadNet, Inc. | RadNet, Inc. | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 23.641 $ | 0,01 | 423 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 23.369 $ | 0,01 | 2.554 | |
| Adlai Nortye Ltd. | Adlai Nortye Ltd. | EC | 00704R109 | Long | Börsenkurs (Stufe 1) | 23.307 $ | 0,01 | 3.368 | |
| Beta Bionics, Inc. | Beta Bionics, Inc. | EC | 08659B102 | Long | Börsenkurs (Stufe 1) | 18.246 $ | 0,01 | 1.821 | |
| Nuvation Bio, Inc. | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 16.525 $ | 0,01 | 3.852 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 15.596 $ | 0,01 | 1.122 | |
| MediWound Ltd. | MediWound Ltd. | EC | IL0011316309 | Long | Börsenkurs (Stufe 1) | 15.240 $ | 0,01 | 946 | |
| Tenax Therapeutics, Inc. | Tenax Therapeutics, Inc. | EC | 88032L605 | Long | Börsenkurs (Stufe 1) | 13.464 $ | 0,01 | 842 | |
| Ginkgo Bioworks Holdings, Inc. | Ginkgo Bioworks Holdings, Inc., Class A | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 8.251 $ | 0,01 | 1.346 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 2.843 $ | 0,00 | 1.057 | |
| 158.170.714 $ | 99,51 | 2.361.595 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.